The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53. (Q38340912)

2 September 2017

The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53. (English)

1 reference

2 September 2017

Patricia Stanhope-Baker

1

1 reference

2 September 2017

Patricia M Kessler

2

1 reference

2 September 2017

Wenliang Li

3

1 reference

2 September 2017

Munna L Agarwal

4

1 reference

2 September 2017

Bryan R G Williams

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

21 May 2004

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

279

1 reference

2 September 2017

32

1 reference

2 September 2017

33575-33585

1 reference

Wilms tumor and the WT1 gene

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Physical and functional interaction between WT1 and p53 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Anaplastic Wilms' tumor: clinical and pathologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Wilms' tumor in the Li-Fraumeni cancer family syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Identification of connective tissue growth factor as a target of WT1 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Phenotypic modulation of parietal epithelial cells of Bowman's capsule in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Coexamination of site-specific transcription factor binding and promoter activity in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Unravelling the activation mechanisms of protein kinase B/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Characterization of the p53-rescue drug CP-31398 in vitro and in living cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

The p53MH algorithm and its application in detecting p53-responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Regulation of p53 downstream genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Wild-type p53 negatively regulates the expression of a microtubule-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Neurophilin-1 is a downstream target of transcription factor Ets-1 in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

The role of WT1 in oncogenesis: tumor suppressor or oncogene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

Transcriptional Regulation of the p21(WAF1/CIP1)Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404787200

21 January 2018

Identifiers

DOI

10.1074/JBC.M404787200

1 reference

2 September 2017

1 reference